{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:38:14Z","timestamp":1792636694745,"version":"4.5.0"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Patients with nephrotic syndrome (NS) treated with glucocorticoids often suffer from growth disorders. This study aimed to explore the impact of recombinant human growth hormone treatment in children with growth disorders secondary to NS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective study enrolled patients with NS treated at Guangzhou Women and Children's Medical Center between May 2015 and November 2023. Patients were divided into the recombinant human growth hormone group and the conventional group. The primary outcome was height increment. Secondary outcomes included height standard deviation score, predicted adult height standard deviation score, and height velocity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 129 enrolled children (89 in the recombinant human growth hormone group, 40 in the conventional group), the recombinant human growth hormone group showed significantly greater height increments at 6 months (4.80 \u00b1 1.42 vs. 2.02 \u00b1 0.91\u2005cm), 12 months (9.07 \u00b1 2.46 vs. 4.39 \u00b1 1.73\u2005cm), and 24 months (15.34 \u00b1 5.20 vs. 7.88 \u00b1 3.43\u2005cm; all P &amp;lt; .001). Similarly, height standard deviation score and predicted adult height standard deviation score improvements were significantly greater in the recombinant human growth hormone group at all time points (all P &amp;lt; .001). Height velocity was also higher in the recombinant human growth hormone group at 6 and 12 months (both P &amp;lt; .001). These associations remained significant after multivariate adjustment. No significant differences in glucocorticoid exposure during follow-up were observed between groups. Multivariate analysis at 12 months indicated that cumulative glucocorticoid dosage was negatively associated with height standard deviation score (\u03b2=\u2212.0022, 95% CI: \u22120.0041, \u22120.0004; P = .020) and predicted adult height (\u03b2=\u2212.0148, 95% CI: \u22120.0288, \u22120.0008; P = .038).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The results suggested that recombinant human growth hormone treatment in children with NS significantly improved height, height standard deviation score, predicted adult height standard deviation score, and height velocities, compared with conventional treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/joneph\/aajag098","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T11:36:14Z","timestamp":1779190574000},"page":"1382-1389","source":"Crossref","is-referenced-by-count":0,"title":["Impact of recombinant human growth hormone treatment in children with growth disorders secondary to nephrotic syndrome"],"prefix":"10.1093","volume":"39","author":[{"given":"Fazhan","family":"Zhong","sequence":"first","affiliation":[{"name":"Department of Nephrology, Guangzhou Women and Children\u2019s Medical Center, Guangzhou Medical University , Guangzhou 510120 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Fan","sequence":"additional","affiliation":[{"name":"Pediatric Emergency Department, Guangzhou Women and Children\u2019s Medical Center, Guangzhou Medical University , Guangzhou 510120 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Guangzhou Women and Children\u2019s Medical Center, Guangzhou Medical University , Guangzhou 510120 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huabin","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Guangzhou Women and Children\u2019s Medical Center, Guangzhou Medical University , Guangzhou 510120 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiying","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Guangzhou Women and Children\u2019s Medical Center, Guangzhou Medical University , Guangzhou 510120 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Guangzhou Women and Children\u2019s Medical Center, Guangzhou Medical University , Guangzhou 510120 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiqing","family":"Li","sequence":"additional","affiliation":[{"name":"Pediatric Emergency Department, Guangzhou Women and Children\u2019s Medical Center, Guangzhou Medical University , Guangzhou 510120 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7741-5712","authenticated-orcid":false,"given":"Xia","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Guangzhou Women and Children\u2019s Medical Center, Guangzhou Medical University , Guangzhou 510120 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"key":"2026102121373304700_aajag098-B1","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","article-title":"KDIGO 2021 clinical practice guideline for the management of glomerular diseases","volume":"100","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group","year":"2021","journal-title":"Kidney Int"},{"key":"2026102121373304700_aajag098-B2","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1080\/20469047.2017.1374003","article-title":"Nephrotic syndrome in infants and children: pathophysiology and management","volume":"37","author":"Downie","year":"2017","journal-title":"Paediatr Int Child Health"},{"key":"2026102121373304700_aajag098-B3","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1542\/pir.36-3-117","article-title":"Nephrotic syndrome","volume":"36","author":"Andolino","year":"2015","journal-title":"Pediatr Rev"},{"key":"2026102121373304700_aajag098-B4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3389\/fped.2016.00039","article-title":"Ethnic differences in childhood nephrotic syndrome","volume":"4","author":"Chanchlani","year":"2016","journal-title":"Front Pediatr"},{"key":"2026102121373304700_aajag098-B5","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3760\/cma.j.issn.0578-1310.2009.03.003","article-title":"Evidence-based guidelines on diagnosis and treatment of childhood common renal diseases (I) evidence-based guideline on diagnosis and treatment of steroid-sensitive, relapsing\/steroid-dependent nephrotic syndrome (for trial implementation)","volume":"47","author":"SoP The Subspecialty Group of Nephrology, Chinese Medical Association","year":"2009","journal-title":"Zhonghua Er Ke Za Zhi."},{"key":"2026102121373304700_aajag098-B6","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1007\/s00467-020-04519-1","article-title":"IPNA clinical practice recommendations for the diagnosis and management of children with steroid-resistant nephrotic syndrome","volume":"35","author":"Trautmann","year":"2020","journal-title":"Pediatr Nephrol"},{"key":"2026102121373304700_aajag098-B7","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s00467-022-05739-3","article-title":"IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome","volume":"38","author":"Trautmann","year":"2023","journal-title":"Pediatr Nephrol"},{"key":"2026102121373304700_aajag098-B8","doi-asserted-by":"publisher","first-page":"e2.53","DOI":"10.1136\/archdischild-2016-311535.57","article-title":"Long-course oral corticosteroid toxicity in children","volume":"101","author":"Aljebab","year":"2016","journal-title":"Arch Dis Child"},{"key":"2026102121373304700_aajag098-B9","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41581-019-0161-4","article-title":"Clinical practice recommendations for growth hormone treatment in children with chronic kidney disease","volume":"15","author":"Drube","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"2026102121373304700_aajag098-B10","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1007\/s00467-002-0838-x","article-title":"Growth failure, risk of hospitalization and death for children with end-stage renal disease","volume":"17","author":"Furth","year":"2002","journal-title":"Pediatr Nephrol"},{"key":"2026102121373304700_aajag098-B11","doi-asserted-by":"publisher","first-page":"970946","DOI":"10.1155\/2013\/970946","article-title":"Growth retardation in children with kidney disease","volume":"2013","author":"Salas","year":"2013","journal-title":"Int J Endocrinol"},{"key":"2026102121373304700_aajag098-B12","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1542\/pir.2020-001883","article-title":"Failure to thrive or growth faltering: medical, developmental\/behavioral, nutritional, and social dimensions","volume":"42","author":"Tang","year":"2021","journal-title":"Pediatr Rev."},{"key":"2026102121373304700_aajag098-B13","doi-asserted-by":"publisher","first-page":"S82","DOI":"10.1016\/j.jcf.2019.08.010","article-title":"Growth failure and treatment in cystic fibrosis","volume":"18","author":"Le","year":"2019","journal-title":"J Cyst Fibros"},{"key":"2026102121373304700_aajag098-B14","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1203\/00006450-200208000-00003","article-title":"Interactions between GH, IGF-I, glucocorticoids, and thyroid hormones during skeletal growth","volume":"52","author":"Robson","year":"2002","journal-title":"Pediatr Res."},{"key":"2026102121373304700_aajag098-B15","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1186\/s13023-022-02590-5","article-title":"Growth hormone treatment improves final height in children with X-linked hypophosphatemia","volume":"17","author":"Andr\u00e9","year":"2022","journal-title":"Orphanet J Rare Dis."},{"key":"2026102121373304700_aajag098-B16","doi-asserted-by":"publisher","first-page":"101331","DOI":"10.1016\/j.ghir.2020.101331","article-title":"Comparison of the efficacy and safety of recombinant human growth hormone in treating idiopathic short stature and growth hormone deficiency in children","volume":"53-54","author":"Hou","year":"2020","journal-title":"Growth Horm IGF Res."},{"key":"2026102121373304700_aajag098-B17","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.12669\/pjms.38.7.6535","article-title":"Significance of recombinant human growth hormone therapy in promoting growth and development of children with idiopathic short stature","volume":"38","author":"Han","year":"2022","journal-title":"Pak J Med Sci"},{"key":"2026102121373304700_aajag098-B18","doi-asserted-by":"publisher","first-page":"Cd003264","DOI":"10.1002\/14651858.CD003264.pub3","article-title":"Growth hormone for children with chronic kidney disease","volume":"2012","author":"Hodson","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"2026102121373304700_aajag098-B19","first-page":"3","article-title":"GH therapy in non\u2013growth hormone-deficient children","volume":"12","author":"Guzzetti","year":"2025","journal-title":"Children (Basel)"},{"key":"2026102121373304700_aajag098-B20","doi-asserted-by":"publisher","first-page":"e14803","DOI":"10.1111\/petr.14803","article-title":"Over three decades of growth hormone treatment in children with chronic kidney disease-associated growth failure before and after kidney transplantation","volume":"28","author":"Yadin","year":"2024","journal-title":"Pediatr Transplant"},{"key":"2026102121373304700_aajag098-B21","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1053\/j.ajkd.2008.11.017","article-title":"KDOQI clinical practice guideline for nutrition in children with CKD: 2008 update. Executive summary","volume":"53","author":"KW Group","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"2026102121373304700_aajag098-B22","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3760\/cma.j.issn.0578-1310.2008.06.107","article-title":"Guidelines for diagnosis and treatment of children with short stature","volume":"46","author":"Subspecialty Group of Endocrinologic, Hereditary and Metabolic Diseases","year":"2008","journal-title":"Zhonghua Er Ke Za Zhi."},{"key":"2026102121373304700_aajag098-B23","first-page":"609","article-title":"A national survey on growth of children under 7 years of age in nine cities of China, 2005","volume":"48","author":"Coordinating Study Group of Nine Cities on Physical Growth and Development of Children","year":"2007","journal-title":"Zhonghua Er Ke Za Zhi."},{"key":"2026102121373304700_aajag098-B24","doi-asserted-by":"crossref","first-page":"301","DOI":"10.5603\/EP.a2021.0039","article-title":"The validity of the Bayley-Pinneau method in predicting final adult height at the onset of puberty in patients with classic congenital adrenal hyperplasia","volume":"72","author":"Badawi","year":"2021","journal-title":"Endokrynol Pol"},{"key":"2026102121373304700_aajag098-B25","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/s0022-3476(97)80023-6","article-title":"Efficacy and safety of one year of growth hormone therapy in steroid-dependent nephrotic syndrome","volume":"130","author":"Loke","year":"1997","journal-title":"J Pediatr"},{"key":"2026102121373304700_aajag098-B26","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.2169\/internalmedicine.49.3483","article-title":"Successful treatment of dwarfism secondary to long-term steroid therapy in steroid-dependent nephrotic syndrome","volume":"49","author":"Sun","year":"2010","journal-title":"Intern Med"},{"key":"2026102121373304700_aajag098-B27","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1530\/eje.0.1440237","article-title":"IGFs and IGF-binding proteins in short children with steroid-dependent nephrotic syndrome on chronic glucocorticoids: changes with 1 year exogenous GH","volume":"144","author":"Zhou","year":"2001","journal-title":"Eur J Endocrinol"},{"key":"2026102121373304700_aajag098-B28","doi-asserted-by":"publisher","first-page":"4578","DOI":"10.1210\/jc.2017-01455","article-title":"Growth outcomes after GH therapy of patients given long-term corticosteroids for juvenile idiopathic arthritis","volume":"102","author":"David","year":"2017","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/joneph\/article-pdf\/39\/7\/1382\/71089705\/aajag098.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/joneph\/article-pdf\/39\/7\/1382\/71089705\/aajag098.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:37:37Z","timestamp":1792633057000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/39\/7\/1382\/8796093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":28,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,9,15]]},"published-print":{"date-parts":[[2026,10,22]]}},"URL":"https:\/\/doi.org\/10.1093\/joneph\/aajag098","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,9]]}}}